Pay in 4 interest-free payments of $24.20 Learn more
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4
2-[4-[4-(2
In order to examine the role of PKC in p38MAPK phosphorylation
at least in part
2119/molmed
(2013) AACR poster 491
Ivacaftor (benzenesulfonate) Catalog No.:M9558-2 2-[4-[4-(2VX 770, is a drug used to treat cystic fibrosis in people with certain mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene, who account for 45% cases of cystic fibrosis, and is included in a combination drug, lumacaftor ivacaftor, which is used to treat people with cystic fibrosis who have the F508del mutation in CFTR. Ivacaftor is a "potentiator" of CFTR, meaning it increases the probability that the defective channel